Sign In
Buy ZBH
$84.98
+1.23 (+1.47%)
At Close: Jun 03, 2026
Reasons to Retain ZBH Stock in Your Portfolio for Now
09:51am, Friday, 06'th Dec 2024
Zimmer Biomet's robust efforts to expand market share and a gradually stabilizing musculoskeletal market appear promising.
ZBH Stock Might Rise Following FDA Nod for Knee Implant Component
08:55am, Thursday, 05'th Dec 2024
Zimmer Biomet's Persona SoluTion Porous Plasma Spray Femur gets FDA 510(k) approval. The company expects to launch the system in the first quarter of 2025.
Zimmer Biomet Receives FDA Clearance for Persona® SoluTion™ PPS® Femur
07:30am, Wednesday, 04'th Dec 2024
A Total Knee Replacement Alternative for Patients with Metal and/or Bone Cement Sensitivities WARSAW, Ind., Dec. 4, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global med
Why Is Zimmer (ZBH) Up 4.8% Since Last Earnings Report?
12:36pm, Friday, 29'th Nov 2024
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
ZBH Stock Gains From FDA Nod for Oxford Cementless Partial Knee
10:35am, Tuesday, 26'th Nov 2024
Zimmer Biomet receives FDA nod for the Oxford Cementless Partial Knee. It is a PMA Supplement approval.
WARSAW, Ind., Nov. 25, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) Premarket A
Zimmer Biomet to Present at Citi's 2024 Global Healthcare Conference
07:30am, Thursday, 21'st Nov 2024
WARSAW, Ind. , Nov. 21, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will participate in the Citi Global Heal
ZBH Stock Gains From Receiving CE Mark for Persona Revision Knee System
08:21am, Wednesday, 20'th Nov 2024
Zimmer Biomet gets CE Mark Certification for Persona Revision Knee System, followed by the successful introduction in the United States and other markets.
Zimmer Biomet Announces CE Mark Certification for Persona® Revision Knee System
07:30am, Monday, 18'th Nov 2024
WARSAW, Ind., and ZURICH , Nov. 18, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE: ZBH and SIX: ZBH), a global medical technology leader, today received the CE Mark for its Persona® Revisi
ZBH Stock to Gain Support From Market Share Gains Amid Macro Issues
11:25am, Monday, 11'th Nov 2024
Zimmer Biomet expects ROSA and Persona Cementless Knee to enhance its robotics and cementless market penetration to 50% to 60% range at a rapid pace.
Orthopedic Implant Maker Zimmer Biomet Reports Better-Than-Expected Q3 Earnings, Updates Annual Forecasts
12:04pm, Wednesday, 30'th Oct 2024
On Wednesday, Zimmer Biomet Holdings, Inc ZBH reported third-quarter adjusted EPS of $1.74, up from $1.65 a year ago, in line with the Street estimates.
ZBH Stock Up Despite Q3 Earnings Miss, 2024 View Narrowed
11:56am, Wednesday, 30'th Oct 2024
Zimmer Biomet delivers strong performance across segments and regions in the third quarter of 2024.
Zimmer Biomet Holdings, Inc. (ZBH) Q3 2024 Earnings Call Transcript
10:58am, Wednesday, 30'th Oct 2024
Zimmer Biomet Holdings, Inc. (NYSE:ZBH ) Q3 2024 Earnings Conference Call October 30, 2024 8:30 AM ET Company Participants David DeMartino – Senior Vice President-Investor Relations Ivan Tornos –
Zimmer (ZBH) Reports Q3 Earnings: What Key Metrics Have to Say
10:35am, Wednesday, 30'th Oct 2024
Although the revenue and EPS for Zimmer (ZBH) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Stree
Implant maker Zimmer Biomet lowers full-year profit forecast
09:22am, Wednesday, 30'th Oct 2024
Hip implant maker Zimmer Biomet lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations.
